Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Biochem Pharmacol. 2019 Mar 21;164:188–204. doi: 10.1016/j.bcp.2019.03.033

Table 3.

Endogenous and synthetic inhibitors of ADAMs and ADAMTS.

Inhibitor Target Reference
Endogenous:
TIMP-1
ADAM-10, 17 [194]
TIMP-2 ADAM-17, 33 [195]
ADAMTS-1
TIMP-3 ADAM-10, 12, 17, 28, 33 [41, 55, 194,
ADAMTS-1, 2, 4, 5 196]
TIMP-4 ADAM-17, 28, 33 [197]
α−2 macroglobulin ADAMTS-2, 4, 5 [41, 55, 198]
Papilin ADAMTS-2 [60]
Synthetic:
Batimastat (BB-94)
ADAM-17, MMPs [197]
Calcium pentosan polysulfate ADAMTS-7, 12 [199]
CGS27023 ADAM-9 [200]
Cis-1(S)2(R)-amino-2-indanol-based compounds ADAMTS-4, 5 [201]
GI254023 ADAM-10 [16]
GI254023X ADAM-10, MMP9 [16]
Granulin-epithelin precursor ADAMTS-7, 12 [172]
GW280264 ADAM-10, 17 [16]
INCB3619 ADAM-8, 9, 10, 17, 33 [16]
KP457 ADAM-10, ADAM 17 [16]
TAPI-1 ADAM-17/TACE [202]
TAPI-2 TACE, ADAMs, MMPs [202]